(Total Views: 546)
Posted On: 06/06/2019 5:22:51 PM
Post# of 39593
$DECN $KSHB $JNJ
DECN Today Launches its GenUltimate TGB Product into Select International Markets
DECN Awaits Major Counter Proposition from Two Entities as JNJ Litigation Heats up
LOS ANGELES, CA June 6, 2019 - Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year old, diabetes-focused FDA Registered bio-technology worldwide company has received a fourth unsolicited proposition for a strategic transaction involving our GenUltimate! TBG system, Read More. See Complete Information: http://www.thestreetnow.com/spotlight/dailynews/.....
DECN Today Launches its GenUltimate TGB Product into Select International Markets
DECN Awaits Major Counter Proposition from Two Entities as JNJ Litigation Heats up
LOS ANGELES, CA June 6, 2019 - Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year old, diabetes-focused FDA Registered bio-technology worldwide company has received a fourth unsolicited proposition for a strategic transaction involving our GenUltimate! TBG system, Read More. See Complete Information: http://www.thestreetnow.com/spotlight/dailynews/.....
(0)
(0)
